Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites

Progressive elevations of fibroblastic growth factor 23 [FGF23] in chronic kidney disease may reduce serum 25-hydroxyvitamin D [25(OH)] and 1,25-dihydroxyvitamin D [1,25(OH)2D] levels, via stimulation of 24-hydroxylase (Cyp24A1) mediated catabolism of these vitamin D metabolites. To test this possib...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Bing, David, Valentin, Alshayeb, Hala M., Showkat, A., Gyamlani, G, Horst, Ronald L., Wall, Barry M., Quarles, L. Darryl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461248/
https://www.ncbi.nlm.nih.gov/pubmed/22739976
http://dx.doi.org/10.1038/ki.2012.222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461248/
https://www.ncbi.nlm.nih.gov/pubmed/22739976
http://dx.doi.org/10.1038/ki.2012.222

Ejemplares similares